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 Allergic contact dermatitis (ACD) caused by re-
active haptens and metal ions, a form of delayed 
type hypersensitivity, is one of the most com-
mon skin diseases ( 1, 2 ). Contact hypersensitivity 
(CHS), the recognized mouse model for study-
ing human ACD, involves painting a small area 
of abdominal skin with the allergen (sensiti-
zation), e.g., 2,4,6-trinitro-1-chlorobenzene 
(TNCB), followed by an epicutaneous challenge 
5 d later on a previously unexposed site, usually 
the ear (elicitation). The CHS response is then 
measured as the increase in ear thickness 24 h 
later. During the sensitizing contact, the hapten 
binds to proteins in the skin, altering their anti-
genic specifi city, and the newly created antigens 
are then processed by epidermal (Langerhans 
cells) and dermal DCs. A crucial event in this 
sensitization phase is the induction of a tran-
sient skin infl ammation via activation of the 
innate immune system, culminating in the mi-
gration of activated DC, bearing hapten – peptide 
complexes, to the draining lymph nodes ( 1, 2 ). 
During this time, DCs up-regulate costimula-
tory molecules on their surface, produce IL-12 
( 3 ), and polarize to a Th1/Tc1 (CD8 + cyto-
toxic type 1 T cells)-inducing DC phenotype 
( 1, 4 ). After completing their maturation, the 
immigrated DC prime hapten-specifi c naive T 
cells in an IL-12 – dependent manner ( 5 ), giving 
CORRESPONDENCE  
 Stefan F. Martin: 
 stefan.martin@
uniklinik-freiburg.de 
 OR 
Marina A. Freudenberg: 
 freudenberg@immunbio.mpg.de
 Abbreviations used: ACD, al-
lergic contact dermatitis; CHS, 
contact hypersensitivity; HA, 
hyaluronic acid; i.c., intracuta-
neous; ODN, oligodeoxynucle-
otide; TLR, Toll-like receptor; 
TNCB, 2,4,6-trinitro-1-chloro-
benzene; TNBS, 2,4,6-trinitro-
benzene-1-sulfonic acid; TRIF, 
Toll/IL-1 receptor domain –
 containing adaptor-inducing 
interferon-  . 
 S.F. Martin and M.A. Freudenberg contributed equally to this 
paper. 
 The online version of this article contains supplemental material. 
 Toll-like receptor and IL-12 signaling control 
susceptibility to contact hypersensitivity 
 Stefan F.  Martin , 1  Jan C.  Dudda , 1  Eva  Bachtanian , 1  Annalisa  Lembo , 2 
 Stefanie  Liller , 1  Christoph  D ü rr , 1  Markus M.  Heimesaat , 3  Stefan  Bereswill , 3 
 Gy ö rgy  Fejer , 2  Ralitsa  Vassileva , 2  Thilo  Jakob , 1  Nikolaus  Freudenberg , 4 
 Christian C.  Termeer , 1  Caroline  Johner , 2  Chris  Galanos , 2 
and  Marina A.  Freudenberg 2 
 1 Allergy Research Group, Department of Dermatology, University Medical Center Freiburg, D-79104 Freiburg, Germany 
 2 Max Planck Institute for Immunobiology, D-79108 Freiburg, Germany 
 3 Institute for Microbiology and Hygiene, Charit é -Universit ä tsmedizin Berlin, Charit é Campus Mitte, Berlin, Germany 
 4 Institute of Pathology, University Medical Center Freiburg, D-79106 Freiburg, Germany 
 Allergic contact hypersensitivity (CHS) is a T cell – mediated infl ammatory skin disease. 
Interleukin (IL)-12 is considered to be important in the generation of the allergen-specifi c 
T cell response. Loss of IL-12 function in IL-12R  2 – defi cient mice, however, did not ame-
liorate the allergic immune response, suggesting alternate IL-12 – independent pathways in 
the induction of CHS. Because exposure to contact allergens always takes place in the 
presence of microbial skin fl ora, we investigated the potential role of Toll-like receptors 
(TLRs) in the induction of CHS. Using mice defi cient in TLR4, the receptor for bacterial 
lipopolysaccharide (LPS), IL-12 receptor (R)   2, or both, we show that the concomitant 
absence of TLR4 and IL-12R  2, but not the absence of TLR4 or IL-12R  2 alone, prevented 
DC-mediated sensitization, generation of effector T cells, and the subsequent CHS response 
to 2,4,6-trinitro-1-chlorobenzene (TNCB), oxazolone, and fl uorescein isothiocyanate. 
Introduction of the TLR4 transgene into the TLR4/IL-12R  2 mutant restored the CHS 
inducibility, showing a requirement for TLR4 in IL-12 – independent CHS induction. Further-
more, the concomitant absence of TLR2 and TLR4 prevented the induction of CHS to TNCB 
in IL-12 – competent mice. Finally, CHS was inducible in germ-free wild-type and IL-
12R  2 – defi cient mice, but not in germ-free TLR4/IL-12R  2 double defi cient mice, sug-
gesting that the necessary TLR activation may proceed via endogenous ligands. 
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able and that IL-12 defi ciency enhances the allergic response. 
Finally, we show that the development of CHS is abolished 
in mice with an intact IL-12 function but lacking both TLR4 
and TLR2. CHS was also not induced in germ-free IL-
12R  2 – defi cient mice lacking TLR4. The results suggest 
that the TLR activation necessary for sensitization to contact 
allergens may proceed via endogenous TLR ligands. 
 RESULTS 
 Requirement for TLR4 in IL-12 – independent CHS 
 To assess the possible role of TLR4 in the induction of CHS, 
we investigated the response of three genetically distinct strains 
of TLR4-defi cient mice (C57BL/10: H-2 b , BALB/c: H2 d , 
and 129Sv: H-2 b ) to an epicutaneous application of the contact 
allergen TNCB. Because the Th1/Tc1 polarizing cytokine 
IL-12 is still regarded as a dominant factor in CHS induction 
( 3 ), we included in the investigation TLR4 and IL-12R  2 
single- and double-defi cient mice on the same C57BL/10 
background ( 24, 25 ). The TLR4 single-defi cient mice and 
the corresponding WT controls were painted with TNCB and 
rechallenged with the allergen 5 d later. 24 h after rechal-
lenge, all mice developed comparable ear swellings ( Fig. 1 A 
and Fig. S1, available at http://www.jem.org/cgi/content/
full/jem.20070509/DC1), indicating that the sole absence of 
TLR4 had no infl uence on the allergic response. In a similar 
experiment performed in TLR4/IL-12R  2 – defi cient mice, 
a CHS response to TNCB was completely absent ( Fig. 1 A ). 
Furthermore, we found that T cells from the skin-draining 
lymph nodes of TNCB-painted TLR4/IL-12R  2 double-
defi cient mice, in contrast to T cells from WT and TLR4 
single-defi cient animals, exhibited no IFN-  responses to an 
in vitro restimulation with syngeneic spleen cells modifi ed 
with 2,4,6-trinitrobenzene-1-sulfonic acid (TNBS; a water-
soluble analogue of TNCB;  Fig. 1 B ). The absence of CHS 
correlated with the absence of signifi cant cellular infi ltration 
of the ear skin (see  Fig. 3 B ). An absence of CHS in these 
mice was also observed when the contact sensitizers oxazolone 
and FITC were used ( Fig. 1, C and D ). Similarly, lymph node 
cells of oxazolone-sensitized TLR4/IL-12R  2 double-defi -
cient mice, in contrast to those of WT mice, exhibited no 
enhanced IFN-  responses upon stimulation with anti-CD3 
(Fig. S2). Interestingly, the same stimulation of cells from 
FITC-sensitized WT and double-defi cient mice resulted nei-
ther in an increased IFN-  response (Fig. S2) nor in detect-
able IL-4 production (not depicted). Furthermore, although 
edema and cellular infi ltration was present in the skin of FITC-
challenged WT mice after multiple rounds of sensitization, 
eosinophilia, which is typical for a Th2-mediated CHS, was 
completely absent (Fig. S3). These data suggest that the CHS 
response to FITC in C57BL/10 mice, unlike in BALB/c and 
C57BL/6 mice ( 8, 9 ), is not Th2 dependent. 
 Finally, lymph node cells from TNCB-painted TLR4/
IL-12R  2 double-defi cient mice were unable to adoptively 
transfer CHS to naive WT recipients ( Fig. 1 E ). These data 
indicate that mice with a combined TLR4 and IL-12R  2 de-
fi ciency fail to develop the characteristic allergen-specifi c type 1 
rise to allergen-specifi c CD8 + T cells which express skin-spe-
cifi c homing receptors ( 6 ). More recently, however, it was 
suggested that both Th1 and Th2 cells play a role in CHS and 
that their equilibrium is dependent on the identity of the an-
tigen. The crucial role of Th1/Tc1 cells in the induction of 
CHS has been questioned by a study using Tyk2-defi cient 
mice ( 7 ). In this study, sensitization with TNCB resulted in 
an enhanced CHS response despite an impaired IL-12 signal-
ing and Th2 polarization. Furthermore, the FITC-induced 
CHS was shown to be Th2 type driven ( 8, 9 ). Reexposure of 
the sensitized mice to the allergen elicits the infi ltration of 
hapten-specifi c eff ector and memory T cells that orchestrate 
the characteristic local infl ammatory response with edema 
24 – 72 h later. 
 Although considerable information exists on several as-
pects of CHS development, the events leading to the skin 
infl ammation that is necessary for both sensitization and elici-
tation with allergen are not well understood ( 1, 2 ). A striking 
observation is that contact allergens, similar to the highly 
conserved microbial constituents (pathogen-associated mo-
lecular patterns) which are sensed by Toll-like receptors (TLR; 
for review see reference  10 ), activate NF-  B and MAP ki-
nases ( 11 – 14 ). Notably, the infl ammatory reaction resembles 
the local infl ammatory response to pathogen-associated mo-
lecular patterns ( 15, 16 ). This response is accompanied by the 
production of proinfl ammatory cytokines and chemokines, 
up-regulation of costimulatory molecules, and an infl ux of 
blood cells into the infl amed tissue. The skin, as the site of 
exposure to contact allergens, is also continuously exposed to 
environmental microbial fl ora and, thus, to TLR ligands. 
Consequently, participation of TLRs in the CHS induction 
may be envisaged. 
 In mammals, the TLR family consists of at least 11 mem-
bers (for review see reference  10 ). TLR4 acts as the receptor 
for a most potent activator of the innate immune system, 
Gram-negative bacterial LPS ( 17, 18 ). Another member of 
the family, TLR2, recognizes a variety of microbial compo-
nents, including bacterial lipopeptides (for review see refer-
ence  10 ). In addition to microbial ligands, there is evidence 
that endogenous substances may also act as ligands for TLR4 
and TLR2. We demonstrated earlier that oligomeric degra-
dation products of hyaluronic acid (HA) activate human and 
mouse DCs via TLR4 ( 19 ). More recently, HA fragments 
generated in vitro (135 kD) and those purifi ed from human 
serum (peak 200 kD) were shown to activate mouse macro-
phages via TLR4 and TLR2 ( 20 ). Furthermore, HA degra-
dation products and the two TLR receptors were reported to 
participate in the regulation of noninfectious mouse lung in-
jury ( 20, 21 ). In addition, several other endogenous factors, 
including proteins or peptides such as heat shock proteins, 
have been reported to stimulate TLR4 ( 22, 23 ). 
 In this paper, we investigated the possible involvement of 
TLRs in the development of CHS to contact allergens. The 
results reveal a novel role of TLR4 in susceptibility to CHS 
of mice with impaired IL-12 function. We show further that 
the role of IL-12 and TLR4 signaling in CHS is interchange-
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CD8+ eff ector T cells (Tc1) in response to sensitization. The 
evidence that the TNCB-induced CHS in mice on C57BL/10 
background is mediated by Tc1 cells (like that in C57BL/6 
mice [references  26, 27 ]) is presented in Fig. S4 (available at 
http://www.jem.org/cgi/content/full/jem.20070509/DC1). 
It shows that skin-draining lymph node cells of TNCB-painted 
C57BL/10 mice exhibited enhanced IFN-  responses to an in 
vitro restimulation with allergen when depleted of CD4+ T 
cells and no responses when depleted of CD8+ T cells. 
 Interestingly, TLR4-competent mice, which are defi cient 
for IL-12R  2 (C57BL/10;  Fig. 1 A ), exhibited enhanced 
CHS to TNCB. The same was true for all mice tested with an 
impaired IL-12 function, including knockouts for IL-12p35/
p40 (129Sv;  Fig. 2 A ) or the signal transducer and activator of 
transcription, STAT4 (BALB/c;  Fig. 2 B ). Furthermore, cells 
isolated from the draining lymph nodes of TNCB-sensitized 
IL-12R  2 single-defi cient mice exhibited strongly increased 
IFN-  ( Fig. 1 B ) and no detectable IL-4 responses (not de-
picted) to an in vitro restimulation with syngeneic spleen cells 
modifi ed with TNBS. Thus, our results show that the loss of 
IL-12 signaling did not prevent a Tc1 response or lead to Th2/
Tc2 polarization of the CHS response to TNCB. 
 On the whole, the data indicate the existence of two dis-
tinct pathways of sensitization, one IL-12 dependent and the 
other IL-12 independent, and that induction of CHS via the 
IL-12 – independent pathway requires TLR4. To test this, 
we used TLR4/IL-12R  2 double-defi cient mice carrying a 
functional mouse TLR4 as a transgene ( 28 ). The presence of 
the transgene in these mice rescued the inducibility of CHS 
by TNCB ( Fig. 3 A ). Histology of skin slices shows that the 
ear of the TLR4 transgenic mouse is noticeably thicker be-
cause of an edema and a lymphocyte-rich exudate ( Fig. 3 B , 
slices 1 – 4), compared with minimal changes in the TLR4/
IL-12R  2 double-defi cient mouse ( Fig. 3 B , slices 5 – 8). 
These data provide evidence for the essential role of TLR4 in 
the IL-12 – independent pathway of CHS induction. 
 Failure of CHS induction by TNBS-modifi ed DC from TLR4/
IL-12R  2 mice 
 The results obtained so far indicate an impaired generation of 
allergen-specifi c T cells in mice with a combined TLR4 and 
 Figure 1.  Differential CHS response to TNCB in TLR4  /  and IL-
12R  2  /  mice. (A) Different CHS responses in mutant mouse strains. 
Mice of the indicated strains were sensitized on the shaved abdominal 
skin with TNCB or acetone as vehicle control. Ear challenge with TNCB 
was performed 5 d later and the 24-h ear swelling response was mea-
sured. The results represent the increase in ear thickness for groups of 
three mice  ± SD. Differences were statistically signifi cant at P > 0.05 for 
groups compared (marked by *, **, or ***, respectively). One of six indepen-
dent experiments is shown. (B) IFN-  production by lymph node cells 
from mice after CHS. Lymph node cells were isolated 3 d after ear chal-
lenge and stimulated in vitro for 36 h with irradiated spleen cells with or 
w/o TNBS modifi cation. IFN-  production was measured by ELISA. The 
values represent the mean of triplicate measurements  ± SD for lymph 
node cells from pooled mice ( n = 3). One of three independent experi-
ments is shown. (C and D) Lack of CHS to oxazolone and FITC in TLR4/IL-
12R  2 double-defi cient mice. The indicated mouse strains were sensitized 
by abdominal painting with oxazolone (C) or FITC (D) solutions. Ear chal-
lenge was done on day 6. The results represent the increase in ear thick-
ness for groups of three mice  ± SD. Data are representative for three 
independent experiments. (E) Inability of lymph node cells from sensitized 
mutant mice to passively transfer CHS sensitization. The indicated mouse 
strains were sensitized with TNCB by painting of the abdominal skin and 
ears. Skin-draining lymph nodes were pooled on day 5 and lymph node 
cells were adoptively transferred into WT recipients. Ear challenge was 
performed on day 6, and the 24-h swelling reaction was measured. The 
results represent the mean of three mice per group  ± SD. Data are repre-
sentative of three independent experiments. 
 Figure 2.  Increased CHS responses to TNCB in IL-12p70  /  and 
STAT4  /  mice. CHS was induced in IL-12p70 (A) or STAT4-defi cient (B) 
mice as described in  Fig. 1 A . The results represent the increase in ear 
thickness for groups of three mice  ± SD. The data are representative of 
three independent experiments. 
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IL-12 receptor defi ciency. To test the impact of this defi -
ciency on the function of the allergen-presenting DC, we re-
placed the initial TNCB painting with an intracutaneous 
(i.c.) injection of in vitro TNBS-modifi ed myeloid DC 
(DC-TNP) from TLR4/IL-12R  2 – defi cient mice. Injec-
tion of such cells, in contrast to DC-TNP from WT ( Fig. 4 A ) 
and TLR4 single-defi cient mice ( Fig. 4 B ), failed to sensi-
tize WT mice to TNCB challenge. Furthermore, the pres-
ence of the TLR4 transgene restored the sensitizing capability 
of DC-TNP from TLR4/IL-12R  2 – defi cient mice ( Fig. 
4 C ). Moreover, the injection of DC-TNP from WT mice 
successfully sensitized the double-defi cient mice ( Fig. 4 D ). 
These fi ndings provide evidence that the combined absence 
of TLR4 and IL-12R  2 on the allergen-presenting DC is 
responsible for the absence of CHS induction in double-
defi cient mice. 
 Figure 3.  Restoration of CHS response in TLR4/IL-12R  2  /  
mice by TLR4 transgene. (A) Ear swelling response. CHS was induced as 
described in  Fig. 1 A . The results represent the increase in ear thickness for 
groups of three mice  ± SD. Data are representative of three independent 
experiments. (B) Histopathology of the ear. Ear skin from TNCB-sensitized 
TLR4 transgenic (slices 1 – 4) and nontransgenic (slices 5 – 8) TLR4/IL-
12R  2  /  mice 24 h after challenge with vehicle (control: 1, 2, 5, and 6) 
or TNCB (3, 4, 7, and 8). hematoxylin and eosin staining. Bars: (1, 3, 5, and 7) 
400  μ m; (slices 2, 4, 6, and 8) 50  μ m. 
 Figure 4.  Absence of sensitization for CHS by TNP-modifi ed BM-
DC from TLR4/IL-12R  2  /  mice. (A) TLR4/IL-12R  2  /  DC fail to 
sensitize WT mice. WT mice were sensitized by i.c. injection of TNP-modi-
fi ed BM-DC from the indicated mouse strains into the shaved abdominal 
skin. Ear challenge and CHS measurement were performed as in  Fig. 1 A . 
The data represent the mean ear swelling for groups of three mice. One 
representative of two experiments is shown. (B) WT and TLR4-defi cient DC 
effi ciently sensitize WT mice. WT or TLR4-defi cient DC-TNP were injected 
into WT recipient mice. Unmodifi ed WT DC or TLR4/IL-12R  2  /  DC-
TNP were used as controls. The data represent the increase in ear thick-
ness for groups of three mice  ± SD. One representative of three 
experiments is shown. (C) Transgenic TLR4 expression in TLR4/IL-
12R  2  /  DC restores sensitizing potential. WT mice were sensitized for 
CHS by i.c. injection of DC from the indicated strains and CHS elicitation 
was done as in A. The results represent the increase in ear thickness for 
groups of three mice  ± SD. The data are representative of three independent 
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 TLR2 and TLR4 requirement for induction of CHS in IL-12 –
 competent mice 
 The fi nding of the involvement of TLR4 in the IL-12 – inde-
pendent induction of CHS led us to speculate that TLR sig-
naling is required for the induction of CHS, irrespective of 
whether an IL-12 – dependent or  – independent mechanism is 
available for its development. If this were indeed the case, 
another TLR must compensate for the loss of the TLR4 
function in IL-12 – competent TLR4-defi cient mice ( Fig. 1 A ). 
TLR2 appeared to be a suitable candidate because, like TLR4, 
it is expressed on the surface of innate immune cells, recognizes 
 Like TLR4, TLR9 is known to drive the maturation of 
DC and Th1 responses ( 29 – 31 ). We therefore investigated 
whether triggering via TLR9 might rescue the dysfunction 
of TLR4/IL-12R  2 – defi cient DC. DC from WT and dou-
ble-defi cient donors were therefore incubated for 1 h with 
CpG – oligodeoxynucleotides (ODN) before TNBS modi-
fi cation and i.c. injection into WT mice. Preincubation of 
TLR4/IL-12R  2 – defi cient DC with control ODN failed to 
reverse their inability to induce CHS (Fig. S5, available at 
http://www.jem.org/cgi/content/full/jem.20070509/DC1). 
As shown in  Fig. 5 and Fig. S5, the activation via TLR9 en-
dowed the defi cient DC with excellent sensitizing properties, 
suggesting that other members of the TLR family may also 
support the IL-12 – independent CHS. 
 Requirement of additional cytokine-inducing signals 
for the full activation of DC by allergen 
 To examine whether the absence of CHS in TLR4/IL-
12R  2-defi cient mice might be a result of an impaired mi-
gration of allergen-loaded DC to the draining lymph nodes, 
we painted the ears of WT and TLR4/IL-12R  2 – defi cient 
mice with the allergen FITC. Using fl ow cytometry, we ob-
served a similar increase in the number of FITC-positive WT 
and defi cient DC into auricular lymph nodes, excluding im-
paired migration as the reason for the impaired generation of 
allergen-specifi c eff ector T cells ( Fig. 6 ). 
 Induction of IL-12 and of costimulatory molecules on 
DC after exposure to allergen are considered to be crucial 
factors in the effi  cient generation of contact allergen-specifi c 
Tc1 cells. To fi nd out if there was a defect in the activation 
of double-defi cient DC by contact allergen, we stimulated 
DC from WT and TLR4/IL-12R  2 – defi cient mice for 24 h 
with TNBS (water-soluble form of the allergen) or TNCB in 
vitro . This stimulation resulted in the effi  cient up-regulation 
of CD40, CD86, I-A b , and CCR7 ( Fig. 7 A ) on both WT 
and double-defi cient cells. Surprisingly however, both DC 
types failed to produce IL-12p40, IL-6, or IFN-   ( Fig. 7 B ) 
and did not express enhanced levels of IL-23 mRNA ( Fig. 7 C ) 
when stimulated with TNBS. In contrast, WT cells stimu-
lated with LPS (TLR4 ligand) and both DC types stimulated 
with CpG-ODN (TLR9 ligand) did so ( Fig. 7, B and C ). 
The control ODN CpG-GC showed no cytokine-inducing 
activity ( Fig. 7 B ). Furthermore, DC from IL-12R  2 single-
defi cient mice, like those from WT animals, produced cyto-
kines when stimulated with LPS or CpG ODN but not with 
TNBS or control ODN (Fig. S6, available at http://www
.jem.org/cgi/content/full/jem.20070509/DC1). 
 These fi ndings indicate that allergen stimulation alone is 
insuffi  cient for a full activation of allergen-presenting DC and 
that an additional signal is required. This could be provided 
by activation via TLR. 
experiments. (D) WT DC sensitize TLR4/IL-12R  2  /  mice. The ex-
periment was performed as in  Fig. 4 A . One representative of three 
experiments is shown. 
 
 Figure 5.  Restoration of the sensitizing capacity for CHS of TLR4/
IL-12R  2  /  DC-TNP by CpG-ODN pretreatment. The experiment 
was performed as in  Fig. 4 A . However, where indicated, DC were pre-
treated with CpG-ODN for 1 h before i.c. injection. The data represent the 
increase in ear thickness for groups of three mice  ± SD. One representative 
of three experiments is shown. 
 Figure 6.  Normal DC migration in FITC-treated TLR4/IL-
12R  2  /  mice. Mice of the indicated strains received FITC/DBP on 
both ears. Both auricular lymph nodes were removed 24 h later and FITC-
positive DC were detected by fl ow cytometry. The gate was set on CD11c hi /
I-A b hi cells. The values for a single lymph node are shown and are repre-
sentative for three experiments with two individual mice per group. 
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both microbial and endogenous ligands, and exhibits many 
overlapping activities with TLR4 (for review see reference 
 10 ). As shown in  Fig. 8 A , the ear swelling responses of mice 
with disrupted  TLR2 were slightly, but signifi cantly, reduced 
when compared with those of WT controls. The combined 
 Figure 7.  Partial activation of DCs by TNCB. (A) TNCB induces up-
regulation of surface markers on DC. BM-DC from WT or TLR4/IL-
12R  2  /  mice were stimulated for 24 h with 100  μ M TNCB. Surface 
expression of the indicated markers was determined by fl ow cytometry. 
Dashed lines represent untreated control DC and solid lines represent TNCB-
treated DC. (B) TNBS fails to induce cytokine production by DC. DC from WT 
or TLR4/IL-12R  2  /  mice were stimulated for 24 h with 0.75 mM TNBS. 
IL-12, IL-6, and IFN-   production in culture supernatants was determined 
by ELISA. As a control, DC were treated with LPS CpG-ODN or control ODN 
(CpG-GC). The values represent the mean of triplicate measurements  ± SD. 
(C) TNBS fails to up-regulate IL-23 mRNA. The total RNA was isolated from 
DC of WT or TLR4/IL-12R  2  /  mice, stimulated for 3 h with the indicated 
agents. The levels of mRNA for IL-23 were analyzed by quantitative RT-PCR. 
The values represent the mean of triplicate measurements  ± SD. 
 Figure 8.  Lack of CHS induction in mice lacking TLR2 and TLR4. 
(A) Absence of ear swelling reaction in TNCB-sensitized TLR2/TLR4 double-
defi cient mice. CHS was induced as described in  Fig. 1 A . Data are repre-
sentative of three independent experiments. The data represent the 
increase in ear thickness for groups of three mice  ± SD. (B) Absence of 
sensitization for CHS by TNP-modifi ed BM-DC from TLR2/TLR4-defi cient 
mice. The experiment was performed as described in  Fig. 4 A . The data 
represent the increase in ear thickness for groups of three mice  ± SD. One 
representative of two experiments is shown. (C) TLR2 single-defi cient DC 
sensitize WT mice for CHS. The experiment was done as in  Fig. 4 A . The 
data represent the increase in ear thickness for groups of three mice  ± SD. 
(D) Inability of lymph node cells from sensitized TLR2/TLR4-defi cient mice 
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IL-12 receptors are completely resistant to CHS, whereas 
mice lacking only one of the two receptors remain suscepti-
ble, shows that TLR4 and IL-12 receptor can mutually re-
place each other in the induction of CHS. Interestingly, we 
found that loss of IL-12 function predisposed the TLR4-
competent mice to CHS, leading to an enhanced allergic re-
sponse. An enhanced response to TNCB has been reported 
in mice with an impaired IL-12 function caused by the dis-
ruption of  Tyk2 ( 7 ). In that study however, T cells from sen-
sitized Tyk2  /  mice exhibited a high IL-4 and decreased 
IFN-  production (Th2 polarization), whereas in our study, 
T cells of similarly sensitized IL-12 receptor-defi cient mice 
exhibited no IL-4 but a high IFN-  production (Th1/Tc1 
polarization) after rechallenge with the allergen. This may be 
because of the existence of more than one IL-12 – indepen-
dent pathway, all leading to an enhanced CHS response, re-
gardless of the type of T cell polarization. The augmentation 
of CHS in mice with an impaired IL-12 function could be 
explained by a loss of the inhibitory eff ect of IL-12 on IL-17 –
 producing CD8 + T cells ( 33 ), which, according to recent 
reports, participate in the elicitation of CHS ( 33, 34 ). The 
impaired generation of allergen-specifi c T cells in TNCB-
treated TLR4/IL-12R  2 – defi cient mice suggested a de-
fective cross talk between DC and T cells. The inability of 
absence of both TLR2 and TLR4, however, resulted in the 
complete absence of CHS to TNCB ( Fig. 8 A ), indicating 
that in mice with an intact IL-12 – IL-12R system, TLR2 and 
TLR4 are, to a substantial degree, interchangeable with re-
gard to their contribution to the development of CHS. 
 To test the impact of the combined TLR2/TLR4 defi -
ciency on the function of the allergen-presenting DC, we re-
placed the initial TNCB painting by an i.c. injection of in 
vitro TNBS-modifi ed myeloid DC (DC-TNP) from dou-
ble-defi cient mice. Injection of such cells, in contrast to DC-
TNP from WT or TLR2 single-defi cient mice ( Fig. 8, B and 
C ), failed to sensitize WT mice to TNCB. Finally, lymph 
node cells from TNCB-painted TLR2/TLR4 double-defi -
cient mice were unable to adoptively transfer CHS to naive 
WT recipients ( Fig. 8 D ). These fi ndings indicate that in IL-
12 – competent mice, expression of at least one of the two re-
ceptors TLR2 or TLR4 on DC is required for generation of 
allergen-specifi c T cells. 
 Presence of CHS in mice lacking microbial fl ora 
 Because LPS-containing Gram-negative bacteria are part of 
the skin fl ora, we examined the possible involvement of this 
TLR ligand in the induction of CHS. For this purpose, we 
used germ-free mice and investigated their CHS response to 
endotoxin-free TNCB under germ-free conditions. Normal 
ear swelling responses were observed in germ-free TLR- and 
IL-12 – competent NMRI ( Fig. 9 A ), as well as IL-12R  2 
single-defi cient mice ( Fig. 9 B ), showing that both IL-12 –
 dependent and IL-12 – independent CHS proceed also in a 
microbe-free environment. In contrast, in this environment 
IL-12 – independent CHS was absent in TLR4/IL-12R  2 
double-defi cient mice ( Fig. 9 C ). In view of this fi nding, we 
hypothesize that the TLR4 activation, which is essential for 
the induction of both IL-12 – dependent and  – independent 
CHS, may proceed via endogenous ligands. This notion is 
further supported by the data shown in Fig. S7 (available at 
http://www.jem.org/cgi/content/full/jem.20070509/DC1). 
In contrast to BMDC from WT mice (Fig. S7 B), those from 
TLR4/IL-12R  2 double-defi cient mice failed to induce 
CHS in germ-free TLR4/IL-12R  2 double-defi cient mice 
(Fig. S7 A). Interestingly, pretreatment of germ-free NMRI 
mice with an inhibitor of HA ( 32 ) before sensitization signifi -
cantly reduced the CHS response ( Fig. 10 ). These data indicate 
a role of HA in the skin as an endogenous TLR ligand con-
tributing to sensitization for CHS. 
 DISCUSSION 
 Our investigation of the role of TLR4 in the induction of 
CHS has revealed an as yet unknown TLR4-dependent mech-
anism of CHS induction to contact allergens that is indepen-
dent of IL-12. The fi nding that mice lacking both TLR4 and 
to passively transfer CHS sensitization. The data represent the increase in 
ear thickness for groups of three mice  ± SD. The experiment was per-
formed as described in  Fig. 1 E . 
 
 Figure 9.  CHS induction in germ-free mice. CHS was induced as 
described in  Fig. 1 A . Germ-free and conventionally housed NMRI (A), IL-
12R  2 (B), or TLR4/IL-12R  2  /  (C) mutant mice were used. The ear 
swelling reaction was measured 24 h later. Results represent the mean of 
three mice per group  ± SD. Data are representative of two experiments. 
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liferation, and generation of IFN-  – producing CD8 + T cells 
( 43 – 45 ). In this study, LPS-activated TLR4 competent DC, 
as well as both CpG-activated TLR4 competent and defi -
cient DC, produced high levels of IFN-   in vitro. Further-
more, preliminary experiments indicate a substantial induction 
of IFN-  mRNA expression in regional lymph nodes of 
mice between 4 and 18 h after the primary exposure to 
TNCB (unpublished data). Another candidate of interest is 
CD40L. Gorbachev and Fairchild ( 46 ) reported that engage-
ment of CD40 promotes CHS responses and development of 
IFN-  – producing T cells, independently of IL-12. We show 
in this study that exposure to TNCB alone enhances CD40 
expression on DC. In this connection, the induction of 
CD40/CD40L ligand by LPS (i.e., via TLR4) has been re-
ported ( 47, 48 ). 
 The inability of TNCB to induce cytokines in DC ob-
served in this study also raised the question of how IL-12 is 
induced in CHS. The fi nding that TLR2/TLR4 double-
defi cient mice are completely resistant to CHS, whereas mice 
lacking only one of the two receptors remain susceptible, 
shows that these receptors can substitute for each other in the 
induction of CHS in IL-12 – competent mice. It is well docu-
mented that activation of TLR2 and TLR4 on DCs results in 
overlapping, but also distinct, cellular responses ( 49 ). This is 
in part because of the fact that both receptors use the adaptor 
MyD88 for signaling, whereas TLR4 also uses the adaptor 
Toll/IL-1 receptor domain – containing adaptor-inducing in-
terferon-  (TRIF). The TRIF-dependent activation up-reg-
ulates the MyD88-dependent production of proinfl ammatory 
cytokines and exhibits additional eff ects, including induction 
of IFN-   (for review see reference  10 ). The inability of 
TLR2 ligands to activate the TRIF-dependent signaling 
pathway may explain why this receptor is incapable of substi-
tuting for TLR4 in the IL-12 independent CHS. 
 Most interestingly, the development of CHS to TNCB 
in germ-free WT and IL-12R  2 – defi cient mice, but its ab-
sence in germ-free TLR4/IL-12R  2 – defi cient mice, i.e., in 
the absence of microbial fl ora, provides strong support for the 
hypothesis of an involvement of endogenous TLR ligands 
( 22, 23 ) in the sensitization to allergens. Although the iden-
tity of these ligands was not addressed in this study, degrada-
tion products of HA seem to be suitable candidates because 
they can activate TLR4 and TLR2 ( 20, 21 ). HA is abundant 
in the skin as a high molecular mass polymer. It facilitates mi-
gration of skin DC and its fragments can deliver maturational 
signals to DC ( 32, 50 ). Interestingly, DC themselves synthe-
size and possibly also degrade HA ( 50, 51 ). It is worth men-
tioning that shortly after TNCB painting we identifi ed 
biochemical and histochemical changes in HA skin content 
(i.e., a subcutaneous accumulation of HA and its concomitant 
disappearance in the epidermis [reference  1 ] [unpublished 
data]). HA fragments were shown to elicit various proinfl am-
matory processes ( 22 ) and to be responsible for TLR2 and 
TLR4 stimulation in bleomycin-induced lung injury ( 20, 21 ). 
A recent publication reported that the infl ammatory response 
to sterile skin injury is weaker in TLR4-defi cient mice, probably 
allergen-loaded TLR4/IL-12R  2 – defi cient DC to sensitize 
WT or TLR4/IL-12R  2 – defi cient recipients and its full 
restoration by the presence of the TLR4 transgene in double-
defi cient DC is evidence that the induction of IL-12 – independent 
CHS requires TLR4 and that it is suffi  cient when this receptor 
is present only on DC. 
 Although the exact role of TLR4 in the induction of IL-
12 – independent CHS remains to be elucidated, our study 
off ers a possible explanation. We showed in this paper that 
DC stimulated in vitro with TNCB effi  ciently up-regulated 
costimulatory molecules MHC class II and CCR7 but failed 
to elicit cytokine production, which is a prerequisite for a 
successful priming of T cells to contact allergens ( 1, 2 ). This 
function, however, can be provided by stimulation with 
TLR ligands (for review see reference  10 ; this study). There-
fore, TLR4 might be required for the induction of cytokines 
in DC of mice with impaired IL-12 function. Furthermore, 
our study demonstrates that activation through TLR9 can 
replace TLR4 triggering for the generation of functional 
TNP-presenting TLR4/IL-12R  2 – defi cient DC. TLR9, 
the receptor for microbial DNA, is important for recognition 
of certain viruses and bacteria (for review see reference  10 ; 
25 ). It is therefore possible that, particularly in the skin, infec-
tions may provide TLR ligands that support or replace the 
function of TLR4 during sensitization to contact allergens. 
 A possible candidate cytokine induced via TLR4 activa-
tion is IL-23, a member of the IL-12 family ( 35, 36 ). IL-23 is 
inducible via TLR4 ( 37 ) (this study) and, like IL-12, partici-
pates in DC activation and in the enhancement of delayed-
type hypersensitivity responses ( 3 ). IL-23 stimulates, whereas 
IL-12 inhibits, IL-17 – producing CD8+ T cells in CHS ( 33 ). 
In our study, IL-23 would come in question for the induc-
tion of CHS observed in IL-12R  2 – and STAT4-defi cient 
mice but not for the CHS observed in mice defi cient in IL-
12p40 and IL-12p35/p40 or IL-12R  1 because the p40 sub-
unit and the receptor IL-12R  1 chain is shared by both the 
cytokine IL-23 and IL-12 and their receptors, respectively 
( 35, 36 ). A further candidate for IL-12 replacement is IFN-
   . It shares several relevant activities with IL-12, such as the 
generation of activated DC ( 38 – 42 ), stimulation of T cell pro-
 Figure 10.  HA inhbitor Pep-1 reduces CHS in germ-free WT mice. 
 Germ-free NMRI mice were injected with 40  μ g Pep-1 or the control ran-
dom peptide RP in 20  μ l PBS in the right ear pinna 24 and 1 h before sensi-
tization. Mice were sensitized by painting of 20  μ l of 3% TNCB/acetone on 
the right ear. Mice were challenged on day 5 on the left ear with 1% TNCB/
acetone, and ear thickness was measured 24 and 48 h after challenge. Data 
represent the ear swelling reactions for groups of six (RP) and eight (Pep-1) 
mice  ± SD. The peptide sequences were as previously published ( 32 ). 
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Anti – IFN-  (R4-6A2 and XMG1.2) for ELISA was obtained from BD Bio-
sciences. The HA inhibitor Pep-1 and the control peptide RP have been de-
scribed previously ( 32 ) and were obtained from Iris Biotech GmbH. 
 Generation of BM-derived DC.  BM-derived DC (BM-DC) were pre-
pared as previously described ( 26 ). 
 In vitro stimulation of DC.  BM-DC were harvested from cultures on day 
7. Stimulation of 5  × 10 5 DC was done in 2 ml RP-10 for 24 h with 1  μ g/ml 
LPS, 3  μ g/ml CpG-ODN or control ODN, or diff erent concentrations of 
TNCB dissolved in acetone in 24-well plates (BD Biosciences). Unless stated 
otherwise, the TNCB concentration was 0.1 mM. As a control, DC were 
treated with the highest concentration of acetone used (0.1 and 1 vol %). 
This treatment had no eff ect on cell viability or the outcome of the experi-
ments. Stimulation with TNBS was done in triplicate at a concentration of 
0.75 mM TNBS in PBS. As a control, DC were treated with an equal vol-
ume of PBS. Results were similar to those obtained with TNCB. For induc-
tion of IL-23 mRNA, 10 6 DC/ml culture medium were stimulated in 
6-well plates for 3 h. 
 In vitro priming of naive T cells with DC.  Cultures were set up in 
96-well plates using a mixture of 4  × 10 5 spleen/lymph node cells per well 
and 5  × 10 3 unmodifi ed or TNBS-modifi ed BM-DC. IFN-  was mea-
sured by ELISA in supernatants from cultures after 5 d. 
 Immunization and induction of CHS.  For induction of CHS, 100  μ l of 
7% TNCB/acetone or acetone as vehicle control on day 0 was painted on 
the shaved abdomen for sensitization, followed by epicutaneous application 
of 20  μ l of 1% TNCB on the dorsum of both ears of all mice on day 5 for 
elicitation. Alternatively, mice were sensitized by i.c. injection of 3  × 10 5 
unmodifi ed or TNBS-modifi ed DC into two sites of the shaved abdomen in 
2  × 50  μ l PBS as previously described ( 26 ), followed by elicitation as for the 
mice on day 5. Ear measurement was done before and 24 h after ear chal-
lenge using an engineer ’ s micrometer (Mitutoyo). CHS to oxazolone and 
FITC (Sigma-Aldrich) was induced by sensitization on day 0 with 150  μ l of 
3% oxazolone in ethanol (EtOH) or EtOH (vehicle control) or 400  μ l of 
0.2% FITC in 1:1 Ac/DBP (acetone/dibutylphthalate; Sigma-Aldrich) or 
1:1 acetone/Ac/DBP (vehicle control) on the shaved abdominal skin and 
elicitation with 20  μ l 1% oxazolone/EtOH or 0.2% FITC/Ac/DBP on both 
ears on day 6. The 24-h swelling reactions were measured. 
 Adoptive CHS.  Mice of the various donor strains were sensitized by paint-
ing the shaved abdominal skin with 100  μ l of 7% TNCB and both ears with 
20  μ l of 1% TNCB. Auricular, axillary, maxillary, and superfi cial inguinal 
lymph nodes were harvested 5 d later. Single cell suspensions were prepared 
and 2  × 10 7 lymph node cells were injected i.v. into naive WT recipient 
mice. Thickness of both ears of the recipients was measured 24 h after adop-
tive cell transfer before painting with 1% TNCB and the swelling was mea-
sured 24 h after painting. 
 Histology.  Ears from vehicle or allergen-sensitized mice were removed 24 
h after allergen ear challenge and fi xed in 4% buff ered formaldehyde. 5- μ m 
organ slices were prepared and stained with hematoxylin and eosin. 
 In vitro stimulation of T cells after CHS.  Auricular, maxillary, and axil-
lary lymph nodes were pooled and a single cell suspension was prepared. 
Erythrocytes were lysed and 4  × 10 5 cells per well were cocultivated with 
3  × 10 5 irradiated (3,000 rad) C57BL/6 spleen cells modifi ed with 3 mM 
TNBS for 7 min at 37 ° C as previously described ( 26, 27 ). Cultivation was 
done in 96-well U-bottom plates (Corning). 
 In vivo DC migration.  Mice were painted on both sides of each ear with 
50  μ l of 0.2% FITC (Sigma-Aldrich) in Ac/DBP (1:1) or vehicle alone. 
Auricular lymph nodes were removed 24 h later and live FITC-positive DC 
were measured in a CD11c/MHC II I-A b high gate. The positive cells were 
quantifi ed in comparison to the negative fraction in vehicle-treated mice. 
because of a partial loss of HA signaling ( 52 ). These authors 
further demonstrated that a receptor complex consisting of 
TLR4, CD44, and MD-2 is required for full infl ammatory 
response of cultured cells to HA fragments. Importantly, 
CD44  /  mice exhibited an impaired CHS response, which 
is in agreement with the involvement of HA in the induction 
of CHS. In line with this study is the inhibition of sensitization 
for CHS by the HA inhibitor Pep-1 ( 32 ). Interestingly, in our 
study this inhibitor also reduced the CHS response in germ-free 
NMRI mice. This points to a contribution of HA as a poten-
tial TLR2/4 ligand involved in the sensitization for CHS. 
 Apart from HA degradation products, several endogenous 
ligands of TLRs, especially of TLR4, have been reported 
( 22, 23 ). These also come into question as potential endoge-
nous ligands participating in the induction of CHS. 
 In the past, the search for a genetic predisposition to ACD 
concentrated on the MHC linkage but failed to fi nd one. By 
using mice with natural mutations of  IL-12R  and/or  TLR4 , 
our study shows that a genetic predisposition to CHS can de-
pend on mutations in innate immune receptors that critically 
aff ect DC function. In humans, TLR and IL-12/IL-12R 
polymorphisms aff ecting the function of these molecules 
have been described ( 53 – 60 ). The present study, therefore, 
encourages the search for a linkage between polymorphisms 
or mutations in these genes and susceptibility to CHS. 
 MATERIALS AND METHODS 
 Mice.  All mice were bred at the Max Planck Institute under specifi c patho-
gen-free conditions. The following animals of both sexes, 7 – 12 wk of age, 
were used. WT: C57BL/10ScSn, 129/Sv, and BALB/c. NMRI and mutant 
mice: TLR4-deficient (C57BL/10ScN [references  15, 61 ] and BALB/
c lps/lps [reference  62 ]), IL-12R  2 – defi cient (C57BL/10ScSn [reference 
 24 ]), TLR4/IL-12R  2 – defi cient (C57BL/10ScCr [references  24, 61 ]), 
TLR4-transgenic, TLR4/IL-12R  2 – defi cient (TCr-1 [reference  16 ]), IL-
12p40  /  (BALB/c; provided by M. Kopf, Eidgen ö ssische Technische 
Hochschule Z ü rich, Switzerland), IL-12p35/p40  /  (129/Sv [reference 
 61] ), and STAT4  /  (BALB/c [reference  63 ]). 
 Germ-free IL-12R  2 – defi cient and TLR4/IL-12R  2 – defi cient mice 
were generated by embryo transfer into germ-free NMRI pseudopregnant re-
cipient females under germ-free conditions. NMRI, and the defi cient mice 
after weaning, were randomly bred at the Max Planck Institute animal facility 
in plastic isolators on a gamma-irradiated commercial diet and autoclaved 
water ad lib. Feces samples were routinely cultured in Standard I nutrient 
broth and examined for indications of contamination. The absence of bacterial 
skin fl ora was confi rmed by culturing abdominal skin homogenates of germ-
free mice under aerobic and anaerobic conditions. All of the experimental 
procedures were in accordance with institutional, state, and federal guidelines 
on animal welfare. The animal experiments were approved by the Regier-
ungspr ä sidium Freiburg and supervised by the Animal Protection representa-
tives of the Max Planck Institute and the University Medical Center Freiburg. 
 Chemicals and reagents.  TNBS, FITC, and oxazolone were obtained from 
Sigma-Aldrich, TNCB from VeZerf Laborsynthesen GmbH, and synthetic 
CpG-ODN 1668 (TLRgrade) and control ODN 1720 (1668/GC; TLR-
grade) from Qbiogene. All haptens, CpG-ODN, and control ODN were 
LPS-free as tested by Limulus amebocyte assay (Endogen). LPS of  Salmonellosis 
abortus equi was obtained from Alexis Biochemicals. Antibodies for FACS 
analysis to CD40 (3/23), CD86 (GL1), CD11c (HL3), and I-A b (AF6-120.1) 
were obtained from BD Biosciences, to TLR4/MD-2 (MTS510) from Qbio-
gene, and to CCR7 (4B12) from eBioscience and were used as FITC, PE, or 
Biotin conjugates. Streptavidin-Cy-Chrome was obtained from BD Biosciences. 
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 Cytokine detection.  ELISA for IFN-  and IL-4, IL-6, IFN-   , IL-12p40, 
or IL-12p70 was performed as previously described ( 26, 27 ). IFN-  /  was 
detected as previously described using a bioassay ( 64 ). 
 Quantifi cation of IL-23 mRNA levels with reverse transcription and 
real-time PCR.  Total RNA was isolated from 1.8  × 10 7 DC cells by a gua-
nidinium isothiocyanate-phenol-chloroform-isoamyl alcohol procedure ( 65 ) 
as described previously ( 66 ). To exclude DNA contamination, RNA samples 
were treated with RNase free DNase I (Fermentas). cDNA was prepared us-
ing Expand reverse transcription (Roche) and oligo-dT. Real-time PCR 
quantifi cation of RNA expression was done using the LightCycler II system 
(Roche) and the Quantitect SYBR Green PCR kit (QIAGEN) according to 
the manufacturer ’ s instructions. Arbitrary units of relative expression were 
generated by dividing the value obtained for IL-23 by the value of   -actin. 
The following primers were used for   -actin real-time PCR: TGG AAT 
CCT GTG GCA TCC ATG AAA and TAA AAC GCA GCT CAG TAA 
CAG TCC G. For the measurement of IL-23 mRNAs, gene-specifi c prim-
ers from (Mm_Il23a_SG QuantiTect Primer Assay; QIAGEN) were used. 
 Flow cytometry.  Flow cytometry was done as described previously ( 26 ) 
using antibodies obtained from BD Biosciences and a FACScan instrument 
(BD Biosciences) with CellQuest Software (BD Biosciences). 
 Statistics and statistical analysis.  Statistical analysis was conducted using 
one-way analysis of variance with pairwise comparisons according to the 
Student Newman Keuls method using SigmaStat software (version 3.5; Sys-
tat Software, Inc.). Cytokine data were analyzed using Student ’ s  t test. Data 
are shown as means  ± SD. Diff erences between groups as marked by asterisks 
were statistically signifi cant at P  < 0.05. 
 Online Supplemental Materials.  Fig. S1 shows the CHS in TLR4-defi -
cient BALB/c lps/lps mice. Fig. S2 shows the IFN-  production by lymph 
node cells of mice sensitized with oxazolone or FITC. Fig. S3 shows the 
immunohistology of skin lesions after repeated exposure to FITC. Fig. S4 
shows that TNCB-induced CHS in C57BL/10 mice is mediated by Tc1 
cells. Fig. S5 shows the restoration of the sensitizing capacity of TLR4/IL-
12R  2  /  DC-TNP by pretreatment with CpG-ODN. Fig. S6 shows 
that TNBS fails to induce cytokine production in BMDC from IL-
12R  2  /  mice. Fig. S7 shows that only WT DC-TNP induce CHS in 
germ-free IL-12R  2  /  mice. Online supplemental material is available at 
http://www.jem.org/cgi/content/full/jem.20070509/DC1. 
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